Versican V1 overexpression induces a myofibroblast-like phenotype in cultured fibroblasts

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Carthy, Jon M ^a   Meredith, Anna J ^a   Boroomand, Seti ^a   Abraham, Thomas ^a   Luo, Zongshu ^a   Knight, Darryl ^a   McManus, Bruce M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; COLLAGEN TYPE 3; COMPLEMENTARY DNA; FOCAL ADHESION KINASE; ISOPROTEIN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; PROTEOGLYCAN; SMAD2 PROTEIN; UNCLASSIFIED DRUG; VERSICAN; VERSICAN V1; ACTIN; ALPHA-SMOOTH MUSCLE ACTIN, MOUSE; CADHERIN; FOCAL ADHESION KINASE 1; PTK2 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MYOFIBROBLAST; PHOSPHORYLATION; TRANSGENE;

ACTINS; ANIMALS; ANTIGENS, CD29; CADHERINS; CELL DIFFERENTIATION; CELL LINE; COLLAGEN TYPE III; FIBROBLASTS; FOCAL ADHESION KINASE 1; GENE EXPRESSION REGULATION; HUMANS; MICE; MYOFIBROBLASTS; PHENOTYPE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSGENES; VERSICANS;

EID: 84941312363     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133056     Document Type: Article

References (43)

1. Mjaatvedt CH, Yamamura H, Capehart AA, Turner D, Markwald RR. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev Biol 1998; 202: 56-66. PMID: 9758703
2. Geary RL, Nikkari ST, Wagner WD, Williams JK, Adams MR, Dean RH. Wound healing: a paradigm for lumen narrowing after arterial reconstruction. J Vasc Surg 1998; 27: 96-106; discussion 106-108. PMID: 9474087
3. Farb A, Kolodgie FD, Hwang JY, Burke AP, Tefera K, Weber DK, et al. Extracellular matrix changes in stented human coronary arteries. Circulation 2004; 110: 940-947. PMID: 15302784
4. Evanko SP, Raines EW, Ross R, Gold LI, Wight TN. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. Am J Pathol 1998; 152: 533-546. PMID: 9466580
5. Lin H, Wilson JE, Roberts CR, Horley KJ, Winters GL, Costanzo MR, et al. Biglycan, decorin, and versican protein expression patterns in coronary arteriopathy of human cardiac allograft: distinctness as compared to native atherosclerosis. J Heart Lung Transplant 1996; 15: 1233-1247. PMID: 8981209
6. Gupta V, Barzilla JE, Mendez JS, Stephens EH, Lee EL, Collard CD, et al. Abundance and location of proteoglycans and hyaluronan within normal and myxomatous mitral valves. Cardiovasc Pathol 2009; 18: 191-7. doi: 10.1016/j.carpath.2008.05.001 PMID: 18621549
7. Toeda K, Nakamura K, Hirohata S, Hatipoglu OF, Demircan K, Yamawaki H, et al. Versican is induced in infiltrating monocytes in myocardial infarction. Mol Cell Biochem 2005; 280: 47-56. PMID: 16311904
8. Yeung TL, Leung CS, Wong KK, Samimi G, Thompson MS, Liu J, et al. TGF-beta modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment. Cancer Res 2013; 73: 5016-5028. doi: 10.1158/0008-5472.CAN-13-0023 PMID: 23824740
9. Van Bockstal M, Lambein K, Van Gele M, De Vlieghere E, Limame R, Braems G, et al. Differential regulation of extracellular matrix protein expression in carcinoma-associated fibroblasts by TGF-beta1 regulates cancer cell spreading but not adhesion. Oncoscience 2014; 1: 634-648. PMID: 25593993
10. Keire PA, Bressler SL, Lemire JM, Edris B, Rubin BP, Rahmani M, et al. A role for versican in the development of leiomyosarcoma. J Biol Chem 2014; 289: 34089-34103. doi: 10.1074/jbc.M114.607168 PMID: 25320080
11. Merrilees MJ, Ching PS, Beaumont B, Hinek A, Wight TN, Black PN. Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease. Respir Res 2008; 9: 41. doi: 10.1186/1465-9921-9-41 PMID: 18485243
12. Baarsma HA, Menzen MH, Halayko AJ, Meurs H, Kerstjens HA, Gosens R. β-Catenin signaling is required for TGF-beta1-induced extracellular matrix production by airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2011; 301: L956-965. doi: 10.1152/ajplung.00123.2011 PMID: 21908588
13. Rudnicki M, Perco P, Neuwirt H, Noppert SJ, Leierer J, Sunzenauer J, et al. Increased renal versican expression is associated with progression of chronic kidney disease. PLoS One 2012; 7: e44891. PMID: 23024773
14. Carthy JM, Boroomand S, McManus BM. Versican and CD44 in in vitro valvular interstitial cell injury and repair. Cardiovasc Pathol 2012; 21(2): 74-82. doi: 10.1016/j.carpath.2011.03.003 PMID: 21546273
15. Rezai N, Corbel SY, Dabiri D, Kerjner A, Rossi FM, McManus BM, et al. Bone marrow-derived recipient cells in murine transplanted hearts: potential roles and the effect of immunosuppression. Lab Invest 2005; 85: 982-991. PMID: 16205656
16. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007; 2: 329-333. PMID: 17406593
17. Carthy JM, Luo Z, McManus BM. WNT3A induces a contractile and secretory phenotype in cultured vascular smooth muscle cells that is associated with increased gap junction communication. Lab Invest 2012; 92: 246-255. doi: 10.1038/labinvest.2011.164 PMID: 22105568
18. Carthy JM, Garmaroudi FS, Luo Z, McManus BM. Wnt3a induces myofibroblast differentiation by upregulating TGF-beta signaling through SMAD2 in a beta-catenin-dependent manner. PLoS One 2011; 6: e19809. doi: 10.1371/journal.pone.0019809 PMID: 21611174
19. Wu YJ, La Pierre DP, Wu J, Yee AJ, Yang BB. The interaction of versican with its binding partners. Cell Res 2005; 15: 483-494. PMID: 16045811
20. Choocheep K, Hatano S, Takagi H, Watanabe H, Kimata K, Kongtawlert P, et al. Versican facilitates chondrocyte differentiation and regulates joint morphogenesis. J Biol Chem 2010; 285: 21114-21125. doi: 10.1074/jbc.M109.096479 PMID: 20404343
21. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol 2007; 170: 1807-1816. PMID: 17525249
22. Wang JF, Olson ME, Reno CR, Kulyk W, Wright JB, Hart DA. Molecular and cell biology of skin wound healing in a pig model. Connect Tissue Res 200041: 195-211.
23. Wang J, Dodd C, Shankowsky HA, Scott PG, Tredget EE. Deep dermal fibroblasts contribute to hypertrophic scarring. Lab Invest 2008; 88: 1278-1290. doi: 10.1038/labinvest.2008.101 PMID: 18955978
24. Ricciardelli C, Mayne K, Sykes PJ, Raymond WA, McCaul K, Marshall VR, et al. Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin Cancer Res 1998; 4: 963-971. PMID: 9563891
25. Nara Y, Kato Y, Torii Y, Tsuji Y, Nakagaki S, Goto S, et al. Immunohistochemical localization of extracellular matrix components in human breast tumours with special reference to PG-M/versican. Histochem J 1997; 29: 21-30. PMID: 9088942
26. Evanko SP, Angello JC, Wight TN. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19: 1004-1013. PMID: 10195929
27. Ricciardelli C, Russell DL, Ween MP, Mayne K, Suwiwat S, Byers S, et al. Formation of hyaluronanand versican-rich pericellular matrix by prostate cancer cells promotes cell motility. J Biol Chem 2007; 282: 10814-10825. PMID: 17293599
28. Huang R, Merrilees MJ, Braun K, Beaumont B, Lemire J, Clowes, et al. Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury. Circ Res 2006; 98: 370-377. PMID: 16385080
29. Evanko SP, Johnson PY, Braun KR, Underhill CB, Dudhia J, Wight TN. Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch Biochem Biophys 2001; 394: 29-38. PMID: 11566024
30. Cardoso LE, Little PJ, Ballinger ML, Chan CK, Braun KR, Potter-Perigo S, et al. Platelet-derived growth factor differentially regulates the expression and post-translational modification of versican by arterial smooth muscle cells through distinct protein kinase C and extracellular signal-regulated kinase pathways. J Biol Chem 2010; 285: 6987-6995. doi: 10.1074/jbc.M109.088674 PMID: 20042606
31. Kahari VM, Larjava H, Uitto J. Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture. J Biol Chem 1991; 266: 10608-10615. PMID: 2037600
32. Nikitovic D, Zafiropoulos A, Katonis P, Tsatsakis A, Theocharis AD, Karamanos NK, et al. Transforming growth factor-beta as a key molecule triggering the expression of versican isoforms v0 and v1, hyaluronan synthase-2 and synthesis of hyaluronan in malignant osteosarcoma cells. IUBMB Life 2006; 58: 47-53. PMID: 16540432
33. Rahmani M, Read JT, Carthy JM, McDonald PC, Wong BW, Esfandiarei M, et al. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells. J Biol Chem 2005; 280: 13019-13028. PMID: 15668231
34. Wu Y, Chen L, Zheng PS, Yang BB. Beta 1-integrin-mediated glioma cell adhesion and free radicalinduced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican. J Biol Chem 2002; 277: 12294-12301. PMID: 11805102
35. Wu Y, Wu J, Lee DY, Yee A, Cao L, Zhang Y, et al. Versican protects cells from oxidative stressinduced apoptosis. Matrix Biol 2005; 24: 3-13. PMID: 15748997
36. Bensadoun ES, Burke AK, Hogg JC, Roberts CR. Proteoglycan deposition in pulmonary fibrosis. Am J Respir Crit Care Med 1996; 154: 1819-1828. PMID: 8970376
37. Bensadoun ES, Burke AK, Hogg JC, Roberts CR. Proteoglycans in granulomatous lung diseases. Eur Respir J 1997; 10: 2731-2737. PMID: 9493652
38. Xiang YY, Dong H, Wan Y, Li J, Yee A, Yang BB, et al. Versican G3 domain regulates neurite growth and synaptic transmission of hippocampal neurons by activation of epidermal growth factor receptor. J Biol Chem 2006; 281: 19358-19368. PMID: 16648628
39. Sheng W, Wang G, Wang Y, Liang J, Wen J, Zheng PS, et al. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Mol Biol Cell 2005; 16: 1330-1340. PMID: 15635104
40. Hirose J, Kawashima H, Yoshie O, Tashiro K, Miyasaka M. Versican interacts with chemokines and modulates cellular responses. J Biol Chem 2001; 276: 5228-5234. PMID: 11083865
41. Hattori N, Carrino DA, Lauer ME, Vasanji A, Wylie JD, Nelson CM, et al. Pericellular versican regulates the fibroblast-myofibroblast transition. A role for ADAMTS5-mediated proteolysis. J Biol Chem 2011; 286: 34298-310. doi: 10.1074/jbc.M111.254938 PMID: 21828051
42. Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmouliere A, Varga J, et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 2012; 180: 1340-1355. doi: 10.1016/j.ajpath.2012.02.004 PMID: 22387320
43. Sheng W, Wang G, La Pierre DP, Wen J, Deng Z, Wong CK, et al. Versican mediates mesenchymalepithelial transition. Mol Biol Cell 2006; 17: 2009-2020. PMID: 16452631